Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials

Fortrea has signed a definitive agreement to acquire Worldwide Clinical Trials' Early Phase Services division for approximately $45 million in an all-cash transaction. The acquisition includes a 60,000 sq. ft. GLP bioanalytical lab in Austin, a 200-bed clinical pharmacology unit in San Antonio, and a biospecimen storage facility in Pflugerville, Texas. This strategic move strengthens Fortrea's end-to-end clinical development platform and early-phase capabilities, while allowing Worldwide to focus on its rapidly growing late-stage business across oncology, neuroscience, internal medicine, and rare disease.